MNTA: Momenta Pharmaceuticals Announces Positive Top-Line Phase 3 Results for M923, a Proposed HUMIRA(R) (adalimumab) Biosimilar

New alert via PocketInfo for MNTA:

Momenta Pharmaceuticals Announces Positive Top-Line Phase 3 Results for M923, a Proposed HUMIRA(R) (adalimumab) Biosimilar

Press Releases: http://ir.momentapharma.com/releases.cfm
SEC Filings: http://ir.momentapharma.com/sec.cfm
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8